Atazanavir & Ritonavir Tablets

Atazanavir Sulfate + Ritonavir is classed as a protease inhibitor combination (antiretroviral) and is supplied as tablets. Its standard indications include HIV-1 infection (combination therapy), and it is offered for pharmaceutical supply and export.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.